Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Towers Regulatory News (HTWS)

Share Price Information for Helios Towers (HTWS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 100.40
Bid: 100.40
Ask: 101.00
Change: 0.50 (0.50%)
Spread: 0.60 (0.598%)
Open: 103.40
High: 103.40
Low: 100.00
Prev. Close: 99.90
HTWS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2022 Annual General Meeting Results

28 Apr 2022 14:58

RNS Number : 7489J
Helios Towers PLC
28 April 2022
 

Helios Towers plc (the "Company")

 

2022 Annual General Meeting ("AGM") Results

 

At the Company's AGM held at 10.00 a.m. today, Thursday 28 April 2022, all of the resolutions put to the meeting were passed on a poll vote. The results are set out below.

 

The full text of all the resolutions can be found in the Notice of AGM, which is available for viewing at the National Storage Mechanism, which can be located at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and from the Company's investor relations website at https://www.heliostowers.com/investors/annual-general-meeting/.

 

 

In Favour (including Discretionary)

Against

Total Votes Cast

Votes Withheld

Resolutions

No. of Votes

% of Votes

No. of Votes

% of Votes

No. of Votes

% of issued share capital voted

No. of Votes

 

Ordinary resolutions

 

1. To receive the Annual Report and Accounts for the year ended 31 December 2021.

973,868,602

99.99%

62,704

0.01%

973,931,306

92.93%

1,041,286

2. To approve the annual statement by the Chairman of the Remuneration Committee and the Directors' Remuneration Report (excluding the Directors Remuneration Policy) set out on pages 106-123 of the Annual Report and Accounts for the year ended 31 December 2021.

937,930,237

96.20%

37,040,530

3.80%

974,970,767

93.03%

1,825

3. To elect Helis Zulijani-Boye as a Director of the Company.

890,128,107

91.30%

84,842,660

8.70%

974,970,767

93.03%

1,825

4. To re-elect Sir Samuel Jonah, KBE, OSG as a Director of the Company.

916,808,438

94.03%

58,162,329

5.97%

974,970,767

93.03%

1,825

5. To re-elect Kash Pandya as a Director of the Company.

890,128,107

91.30%

84,842,660

8.70%

974,970,767

93.03%

1,825

6. To re-elect Tom Greenwood as a Director of the Company.

964,132,101

98.89%

10,838,667

1.11%

974,970,768

93.03%

1,824

7. To re-elect Manjit Dhillon as a Director of the Company.

963,896,529

98.86%

11,074,239

1.14%

974,970,768

93.03%

1,824

8. To re-elect Magnus Mandersson as a Director of the Company.

956,231,511

98.08%

18,739,257

1.92%

974,970,768

93.03%

1,824

9. To re-elect Alison Baker as a Director of the Company.

972,826,579

99.78%

2,144,189

0.22%

974,970,768

93.03%

1,824

10. To re-elect Richard Byrne as a Director of the Company.

895,714,351

91.87%

79,256,416

8.13%

974,970,767

93.03%

1,825

11. To re-elect Temitope Lawani as a Director of the Company.

831,788,580

85.31%

143,182,187

14.69%

974,970,767

93.03%

1,825

12. To re-elect Sally Ashford as a Director of the Company.

956,231,511

98.08%

18,739,257

1.92%

974,970,768

93.03%

1,824

13. To re-elect Carole Wamuyu Wainaina as a Director of the Company.

956,231,511

98.08%

18,739,257

1.92%

974,970,768

93.03%

1,824

14. To reappoint Deloitte LLP as auditor of the Company.

974,310,868

99.93%

659,900

0.07%

974,970,768

93.03%

1,824

15. To authorise the Audit Committee of the Company, for and on behalf of the Directors, to fix the remuneration of the auditors.

974,965,192

100.00%

7,400

0.00%

974,972,592

93.03%

0

16. To authorise the Directors to make political donations and political expenditure up to an aggregate of £100,000.

896,709,862

99.99%

73,615

0.01%

896,783,477

85.57%

78,189,115

17. To authorise the Directors to allot securities pursuant to and in accordance with Section 551 of the Companies Act 2006.

937,981,224

96.21%

36,990,368

3.79%

974,971,592

93.03%

1,000

 

Special resolutions

 

18. To authorise the disapplication of pre-emption rights.

968,742,099

99.36%

6,230,493

0.64%

974,972,592

93.03%

0

19. To authorise the disapplication of pre-emption rights in connection with an acquisition or specified capital investment.

953,174,848

97.76%

21,794,920

2.24%

974,969,768

93.03%

2,824

20. To authorise the Company to make market purchases pursuant to Section 701 of the Companies Act 2006.

974,755,118

99.99%

68,941

0.01%

974,824,059

93.02%

148,533

21. To authorise the Directors to call a general meeting other than an annual general meeting on not less than 14 clear days' notice.

969,051,780

99.39%

5,920,812

0.61%

974,972,592

93.03%

0

 

The total number of shares in issue at the voting date is 1,048,000,000. A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of votes for and against the resolution.

 

In accordance with Listing Rule 9.6.2, a copy of all resolutions passed as special business will shortly be available for inspection on the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

A copy of the voting results shown above will also be made available on the Company's website at https://www.heliostowers.com/investors/annual-general-meeting/.

 

 

Enquiries:

 

 

 

For investor enquiries

investorrelations@heliostowers.com

For media enquiries

Edward Bridges, Stephanie Ellis

 

FTI Consulting LLP

 

+44 (0)20 3727 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBKFBPNBKDAQB
Date   Source Headline
25th Apr 20243:40 pmRNS2024 Annual General Meeting Results
23rd Apr 20247:00 amRNSNotice of Q1 2024 Results Date & Conference Call
22nd Apr 20247:00 amRNSCredit rating upgrade
16th Apr 20242:29 pmRNSDirector/PDMR Shareholding
28th Mar 20248:57 amRNSTotal Voting Rights
25th Mar 202410:31 amRNSDoc re Annual Report and Financial Statements
20th Mar 202412:31 pmRNSDirector/PDMR Shareholding
19th Mar 20242:52 pmRNSHolding(s) in Company
19th Mar 20247:56 amRNSHolding(s) in Company
15th Mar 202412:52 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSResults for the year and quarter ended 31 Dec 2023
26th Jan 20249:00 amRNSDirectorate Change
18th Jan 20247:00 amRNSNotice of FY 2023 Results Date & Conference Call
3rd Nov 20237:05 amRNSBlock Listing Interim Review
2nd Nov 20237:00 amRNSQ3 2023 Results
16th Oct 20237:01 amRNSResults of capped tender offer
16th Oct 20237:00 amRNSResults of Tender Offer for Senior Notes
10th Oct 20237:00 amRNSNotice of Q3 2023 Results Date & Conference Call
3rd Oct 20231:29 pmRNSDirector/PDMR Shareholding
28th Sep 20231:34 pmRNSExtension of Early Tender Time
14th Sep 20237:05 amRNSNew Facilities and tender offer of Senior Notes
14th Sep 20237:00 amRNSUp to $400m Tender Offer for Senior Notes
3rd Aug 20237:00 amRNSHalf-year Report
4th Jul 20237:00 amRNSNotice of H1 2023 Results Date & Conference Call
23rd May 20231:39 pmRNSDirector/PDMR Shareholding
18th May 20232:00 pmRNSDirector/PDMR Shareholding
18th May 20232:00 pmRNSDirectorate Change
18th May 20237:00 amRNSQ1 2023 Results
3rd May 202311:25 amRNSBlock Listing Interim Review
27th Apr 20233:39 pmRNS2023 Annual General Meeting Results
17th Apr 20239:44 amRNSNotice of Q1 2023 Results Date & Conference Call
27th Mar 20232:16 pmRNS2022 Annual Report and 2023 Notice of AGM
16th Mar 20237:00 amRNSFinal Results
27th Jan 20237:00 amRNSNotice of FY2022 Results Date & Conference Call
15th Dec 20225:56 pmRNSHolding in Company
8th Dec 20222:55 pmRNSClosing of tower acquisition in Oman
30th Nov 20227:00 amRNSTotal Voting Rights
25th Nov 20227:00 amRNSUpdate on Omantel Tower Portfolio Acquisition
14th Nov 20227:00 amRNSOmantel Tower Acquisition Long-Stop Date Extension
9th Nov 20228:53 amRNSHolding(s) in Company
3rd Nov 20227:00 amRNSQ3 2022 Results
6th Oct 20227:00 amRNSNotice of Q3 2022 Results Date & Conference Call
3rd Oct 20227:00 amRNSBlock Listing Application
29th Sep 202212:03 pmRNSOmantel Tower Acquisition Long-Stop Date Extension
18th Aug 20227:00 amRNSDirectorate Change
18th Aug 20227:00 amRNSHalf-year Report
13th Jul 20227:00 amRNSNotice of H1 2022 Results Date & Conference Call
5th Jul 20227:00 amRNSOmantel Tower Acquisition Long-Stop Date Extension
21st Jun 202212:49 pmRNSDirector/PDMR Shareholding
17th Jun 202210:27 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.